Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK)

Q: What does CUSIP 69012T305 represent in this 13F holders report?

CUSIP 69012T305 is the security identifier for OTLK - Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share used to aggregate holder disclosures.

Q: How many institutions held OTLK - Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share in Q3 2025?

53 institutional investors reported OTLK - Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share for Q3 2025. Use the holders table for investor-level position and value details.

CUSIP: 69012T305

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class: Equity / Common Stock, par value $0.01 per share
Shares outstanding: 120,049,038
Total 13F shares: 4,077,199
Share change: -1,897,538
Total reported value: $4,321,292
Put/Call ratio: 247%
Price per share: $1.06
Number of holders: 53
Value change: -$2,295,886
Number of buys: 19
Number of sells: 42

Quarterly Holders Quick Answers

What is CUSIP 69012T305?
CUSIP 69012T305 identifies OTLK - Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2025
Previous quarter: Q2 2025

Recent filing periods for CUSIP 69012T305:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of OTLK - Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
GMS Ventures & Investments	13D/G	—	50%	29,040,929	$45,303,849	+$20,057,142	27 May 2025	13D/G
Arun Kumar Pillai	3/4/5	Director, 10%+ Owner	— class O/S missing	22,982,529	$26,085,170	—	01 Feb 2022	3/4/5
Tenshi Healthcare Pte. Ltd.	3/4/5	10%+ Owner	— class O/S missing	22,982,529	$26,085,170	—	21 Apr 2022	3/4/5
Sukhtian Ghiath M.	3/4/5	Director, 10%+ Owner	— mixed-class rows	22,123,787 mixed-class rows	$18,973,302	—	27 May 2025	3/4/5
GREAT POINT PARTNERS LLC	13D/G	—	5%	2,220,000	$4,484,400	$0	30 Jun 2025	13D/G
TANG CAPITAL MANAGEMENT LLC	13D/G	—	3.4%	1,500,000	$3,030,000	-$808,000	30 Jun 2025	13D/G
TANG CAPITAL PARTNERS LP	13D/G	TANG CAPITAL MANAGEMENT, LLC	6.4%	1,682,502	$2,624,703	$0	31 Dec 2024	13D/G
Empery Asset Management, LP	13D/G	—	5%	2,332,948	$2,472,925	-$914,455	30 Sep 2025	13D/G
Schonfeld Strategic Advisors LLC	13F	Company	1.1%	1,364,809	$2,183,692	—	30 Jun 2025	13F
VANGUARD GROUP INC	13F	Company	1%	1,251,598	$2,002,557	—	30 Jun 2025	13F
Terry Dagnon	3/4/5	Chief Operations Officer	— mixed-class rows	845,201 mixed-class rows	$741,221	—	20 Apr 2023	3/4/5
Syntone Ventures LLC	3/4/5	10%+ Owner	— mixed-class rows	2,776,867 mixed-class rows	$716,284	—	15 Apr 2024	3/4/5
MORGAN STANLEY	13F	Company	0.35%	425,599	$680,958	—	30 Jun 2025	13F
Steward Partners Investment Advisory, LLC	13F	Company	0.31%	366,201	$585,921	—	30 Jun 2025	13F
BlackRock, Inc.	13F	Company	0.28%	339,896	$543,834	—	30 Jun 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.28%	338,571	$541,714	—	30 Jun 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.22%	265,631	$425,114	—	30 Jun 2025	13F
Jeff Evanson	3/4/5	CHIEF COMMERCIAL OFFICER	— mixed-class rows	833,459 mixed-class rows	$339,553	—	20 Mar 2024	3/4/5
FMR LLC	13F	Company	0.14%	170,502	$272,803	—	30 Jun 2025	13F
Squarepoint Ops LLC	13F	Company	0.13%	155,624	$248,998	—	30 Jun 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.1%	117,769	$188,430	—	30 Jun 2025	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.09%	106,068	$169,709	—	30 Jun 2025	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.08%	96,979	$155,166	—	30 Jun 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.08%	92,368	$147,789	—	30 Jun 2025	13F
STATE STREET CORP	13F	Company	0.07%	85,452	$136,723	—	30 Jun 2025	13F
XTX Topco Ltd	13F	Company	0.07%	83,150	$133,040	—	30 Jun 2025	13F
SCOTIA CAPITAL INC.	13F	Company	0.06%	73,989	$118,382	—	30 Jun 2025	13F
JANE STREET GROUP, LLC	13F	Company	0.06%	70,807	$113,291	—	30 Jun 2025	13F
UBS Group AG	13F	Company	0.05%	55,124	$88,199	—	30 Jun 2025	13F
NORTHERN TRUST CORP	13F	Company	0.03%	38,996	$62,394	—	30 Jun 2025	13F
Sanctuary Advisors, LLC	13F	Company	0.03%	36,286	$58,058	—	30 Jun 2025	13F
HRT FINANCIAL LP	13F	Company	0.03%	35,399	$56,000	—	30 Jun 2025	13F
COMMONWEALTH EQUITY SERVICES, LLC	13F	Company	0.02%	28,151	$45,000	—	30 Jun 2025	13F
Qube Research & Technologies Ltd	13F	Company	0.02%	27,591	$44,146	—	30 Jun 2025	13F
GROUP ONE TRADING LLC	13F	Company	0.02%	27,304	$43,686	—	30 Jun 2025	13F
MARSHALL WACE, LLP	13F	Company	0.02%	25,564	$40,902	—	30 Jun 2025	13F
Russell Investments Group, Ltd.	13F	Company	0.02%	24,477	$39,163	—	30 Jun 2025	13F
ROYAL BANK OF CANADA	13F	Company	0.02%	24,446	$39,000	—	30 Jun 2025	13F
Christensen, King & Associates Investment Services, Inc.	13F	Company	0.02%	24,330	$38,928	—	30 Jun 2025	13F
Quadrature Capital Ltd	13F	Company	0.02%	21,683	$34,801	—	30 Jun 2025	13F
Lawrence A. Kenyon	3/4/5	Chief Financial Officer, Director	— mixed-class rows	18,446 mixed-class rows	$33,828	—	26 Sep 2024	3/4/5
LVW Advisors, LLC	13F	Company	0.02%	21,000	$33,600	—	30 Jun 2025	13F
CITIGROUP INC	13F	Company	0.01%	17,199	$27,518	—	30 Jun 2025	13F
LPL Financial LLC	13F	Company	0.01%	15,127	$24,203	—	30 Jun 2025	13F
Ground Swell Capital, LLC	13F	Company	0.01%	14,860	$23,776	—	30 Jun 2025	13F
OPPENHEIMER & CO INC	13F	Company	0.01%	14,700	$23,520	—	30 Jun 2025	13F
Jain Global LLC	13F	Company	0.01%	14,200	$22,720	—	30 Jun 2025	13F
Vanguard Personalized Indexing Management, LLC	13F	Company	0.01%	13,233	$21,173	—	30 Jun 2025	13F
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	0.01%	12,157	$19,452	—	30 Jun 2025	13F
IEQ CAPITAL, LLC	13F	Company	0.01%	10,968	$17,549	—	30 Jun 2025	13F

Institutional Holders of Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK) as of Q3 2025

As of 30 Sep 2025, Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,077,199 shares. The largest 10 holders included VANGUARD GROUP INC, Schonfeld Strategic Advisors LLC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MILLENNIUM MANAGEMENT LLC, COMMONWEALTH EQUITY SERVICES, LLC, BANK OF AMERICA CORP /DE/, SIMPLEX TRADING, LLC, and STATE STREET CORP. This page lists 53 institutional shareholders reporting positions in this security for the Q3 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders

Q3 2025 holders

Holder diff

-10

Investor	Q2 2025 Shares	Q3 2025 Shares	Share Diff	Share Chg %	Q2 2025 Value $	Q3 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.